Research Nomenclature Common Brand Names Researchers encountering semaglutide in published literature may find it referenced under commercial names including Ozempic (injectable, type 2 diabetes), Wegovy (injectable, weight management), and Rybelsus (oral tablet)
These minor side effects are most common when patients start taking Rybelsus and other semaglutides or GLP-1 medications
To clarify, even without these risk factors, you can still get these medications but insurance wont cover it and youll need to pay out of pocket
doi:10 Husain M, Birkenfeld AL, Donsmark M, et al
The filed lawsuits claim that while labels mention gastrointestinal problems, they omit serious complications